Not applicableNot Yet RecruitingNCT07765316What this trial is testingTargeting Pathogenic Myelopoiesis in Pancreatic CancerWho this might be right forPancreatic Diseases IRCCS San Raffaele 100
Not applicableUnknownNCT03159819What this trial is testingClinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic AdenocarcinomaWho this might be right forAdvanced Gastric AdenocarcinomaPancreatic Adenocarcinoma Changhai Hospital 24
Early research (Phase 1)Study completedNCT00544193What this trial is testingGemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more City of Hope Medical Center 16
Testing effectiveness (Phase 2)Ended earlyNCT02273752What this trial is testingPharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerWho this might be right forEstrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more Emory University 2
Testing effectiveness (Phase 2)Study completedNCT00059826What this trial is testingAdjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerWho this might be right forPancreatic Cancer Alliance for Clinical Trials in Oncology 89
Testing effectiveness (Phase 2)Study completedNCT00998322What this trial is testingREOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic AdenocarcinomaWho this might be right forMetastatic Pancreatic Adenocarcinoma Oncolytics Biotech 34
Early research (Phase 1)Study completedNCT00462553What this trial is testingSunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsWho this might be right forAdenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT06710756What this trial is testingLead-212 PSV359 Therapy for Patients With Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5 more Perspective Therapeutics 112
Testing effectiveness (Phase 2)Looking for participantsNCT06472388What this trial is testingEverolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more AC Camargo Cancer Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT06825546What this trial is testingIcaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal AdenocarcinomaWho this might be right forAdvanced Pancreatic Ductal Adenocarcinoma Sir Run Run Shaw Hospital 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07803783What this trial is testingCompare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic ChemotherapyWho this might be right forMetastatic Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC) MediLink Therapeutics (Suzhou) Co., Ltd. 320
Not applicableNot Yet RecruitingNCT07608458What this trial is testingScheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing PancreatectomyWho this might be right forHepatocellular CarcinomaPancreas CancerBiliary Tract Neoplasms City of Hope Medical Center 70
Large-scale testing (Phase 3)Study completedNCT03504423What this trial is testingStudy Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the PancreasWho this might be right forPancreatic Cancer Metastatic Cornerstone Pharmaceuticals 528
Not applicableNot Yet RecruitingNCT07115420What this trial is testingImproving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically Placed Internal Stents to Prevent Blockage of a Lumen Apposing Metal StentWho this might be right forMalignant Biliary ObstructionAdvanced Pancreatic Cancer and CholangiocarcinomaInoperable Malignant Biliary Obstruction+1 more Waikato Hospital 100
Not applicableStudy completedNCT01646697What this trial is testingSlide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing SurgeryWho this might be right forPancreatic CancerAdenocarcinoma Ohio State University Comprehensive Cancer Center 90
Early research (Phase 1)Study completedNCT02179970What this trial is testingTo Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal CancersWho this might be right forPancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic CCTU- Cancer Theme 26
Early research (Phase 1)UnknownNCT05557851What this trial is testingMinnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the PancreasWho this might be right forMetastatic Adenocarcinoma of the Pancreas Minneamrita Therapeutics LLC 36
Not applicableUnknownNCT05571956What this trial is testingEstablishment of Pancreas Cancer and Cancer-associated Fibroblast Using EUS-guided Biopsy SamplesWho this might be right forPancreas Adenocarcinoma Ajou University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT05630183What this trial is testingBotensilimab in Participants With Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma Agenus Inc. 81
Large-scale testing (Phase 3)Looking for participantsNCT07805954What this trial is testingStudy of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic AdenocarcinomaWho this might be right forPancreatic CancerPancreatic Cancer MetastaticPDAC+5 more Revolution Medicines, Inc. 400